Status:
UNKNOWN
Prognostic Value of SPECT-imaging Myocardial Perfusion Heterogeneity
Lead Sponsor:
University Hospital, Grenoble
Conditions:
Coronary Artery Disease
Coronary Atherosclerosis
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
Endothelial dysfunction has been demonstrated to be an early marker of coronary artery disease (CAD). On the other hand, myocardial perfusion single photon emission computed tomography (MP-SPECT) is a...
Detailed Description
1. SPECT imaging protocol and analysis Stress tests and SPECTs are performed according to the routine protocols in use in our center. Briefly, at peak stress, patients were injected with thallium-201....
Eligibility Criteria
Inclusion
- Age \> 18 years
- Clinical indication for myocardial perfusion imaging
Exclusion
- Pregnancy
- Breast feeding women
- Severe comorbidity with life expectancy 6 months
- Left bundle branch block on ECG making heteogeneity analysis impossible
- Patient not resident in the Rhône-Alpes region
Key Trial Info
Start Date :
January 1 2015
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
June 1 2022
Estimated Enrollment :
1600 Patients enrolled
Trial Details
Trial ID
NCT02208765
Start Date
January 1 2015
End Date
June 1 2022
Last Update
May 19 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University Hospital
Grenoble, France, 38000